Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

FDA clears Propeller Health sensor to work with Symbocort inhaler

By Sean Whooley | May 26, 2020

Propeller Health announced that it received FDA 510(k) clearance for connecting patients using its Symbicort Inhaler to its digital health platform.

The Madison, Wis.-based company’s digital health platform already connects to inhalers used by asthma and COPD patients, including ones manufactured by Boehringer Ingelheim, GlaxoSmithKline, Novartis and Orion, along with other generic equivalents.

Propeller sensors are designed to attach to existing inhalers and deliver insights on medication to the Propeller app on the user’s smartphone. The information delivered to the app can then be shared with clinicians to help inform treatment plans, according to a news release.

The company said its platform has shown in previous clinical studies to increase asthma control by up to 63% and increase medication adherence by up to 58%. It’s also shown to reduce asthma-related emergency department visits and hospitalizations by as much as 57% and reduce COPD-related healthcare utilization by as much as 35%.

“Our partnership with AstraZeneca will give respiratory patients a tool to help manage their condition and increase their medication adherence, a critical factor in keeping people out of the hospital,” Propeller Health co-founder & CEO David Van Sickle said in the release. “This is an important step in transforming the way people receive preventative care, enabling self-management from home and ensuring that providers have the bandwidth to focus on high-risk patients.”


Filed Under: Drug Delivery
Tagged With: Propeller Health
 

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

Theravision_FDA Revised Carton
Johnson & Johnson is bringing the world’s first drug-eluting contact lens to market
midatech pharma janssen johnson & Johnson
J&J expands it long-acting injectables partnership with Midatech
Evonik launches new Eudratec tech to boost solubility of oral small molecules
PharmaJet Stratis
PharmaJet partner touts interim safety results for needle-free COVID-19 vaccine

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50